25th National Psychopharmacology Update

25th National Psychopharmacology Update is organized by the Nevada Psychiatric Association (NPA). The session is held from Feb 12 - 15, 2020 at Paris Las Vegas, Las Vegas, Nevada, United States of America.

Target Audience:
• Psychiatrists
• Primary Care Physicians
• Physician Assistants
• Nurse Practitioners
• Psychiatric Nurses
• Psychologists
• Therapists
Other healthcare practitioners practice to treat patients with mental disorders must reach out to their local licensing and certification boards to know if their conference meets their continuing education requirements.

Accreditation:
The maximum number of CME credits an attendee can claim is upto 33.50 (25.50 for the Psychopharmacology Update and 8.00 for the Psychiatry Neurology Interface).

Delegates of the American Board of Psychiatry and Neurology (ABPN) have a choice to apply 25.50 of the available 33.50 CME credits to fulfill the ABPN requirement for attaining Self- Assesment (SA) credits. These additional CME credits will help an attendee to meet a portion of the ABPN’s MOC requirements

The Pre-Conference includes 8 credits and the Psychopharmacology Update grants the remaining 25.5 credits, for a maximum of 33.5 available credits.

Physicians:
The University of Nevada School of Medicine assigns this live session for a maximum of 33.50 AMA PRA Category 1 Credits™. A medical professional can collect only the credit commensurate with the extent of their participation throughout the session.

Nurses:
The University of Nevada School of Medicine accreditated this live symposium for a maximum of 33.50 AMA PRA Category 1 Credits™.

Self-Assessment CME Credits:
The American Board of Psychiatry and Neurology has evaluated the National Psychopharmacology Update conference and has authorized this session on behalf of the Self-Assessment Program. It is managed by the ABMS as a core component of Maintenance of Certification. This activity contributes a maximum of 25.5 Self-Assessment CME credits.

Description:
The NPA Psychopharmacology Update is one of the nation’s extensive conferences in the field. It renders the complete modern-day information on the psychopharmacological treatment of psychiatric disorders that are most commonly encountered in clinical practice.

The four-day session will bring together more than 1,500 mental health clinicians all the way from the United States, Canada and abroad, including a broad range of exhibitors displaying innovative products and services.

The symposium is sponsored by the Nevada Psychiatric Association, an official district branch of the American Psychiatric Association.

Additional details will be posted as soon as information is available.